Have a personal or library account? Click to login
Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin Cover

Evaluation of the impact of the proteasome inhibitor on calcium channel expression in cardiomyocytes treated with doxorubicin

Current Issues in Pharmacy and Medical Sciences
Volume 31 (2018): Issue 1 (March 2018)
By: Agnieszka Korga,  Milena Soroka,  Karolina Wicha,  Ewelina Humeniuk,  Grzegorz Adamczuk,  Magdalena Iwan,  Marcin Sysa and  Jaroslaw Dudka  
Open Access
|Apr 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.1515/cipms-2018-0004 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 18 - 21
Submitted on: Sep 25, 2017
|
Accepted on: Nov 13, 2017
|
Published on: Apr 11, 2018
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
doxorubicin,
bortezomib,
proteasome,
cardiotoxicity,
calcium channels
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2018 Agnieszka Korga, Milena Soroka, Karolina Wicha, Ewelina Humeniuk, Grzegorz Adamczuk, Magdalena Iwan, Marcin Sysa, Jaroslaw Dudka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 31 (2018): Issue 1 (March 2018)Next article